281 related articles for article (PubMed ID: 15735002)
1. A novel transgenic mouse model reveals humanlike regulation of an 8-kbp human TERT gene promoter fragment in normal and tumor tissues.
Ritz JM; Kühle O; Riethdorf S; Sipos B; Deppert W; Englert C; Günes C
Cancer Res; 2005 Feb; 65(4):1187-96. PubMed ID: 15735002
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of human and mouse telomerase reverse transcriptase (TERT) promoter activity during testis development.
Weise JM; Güneş C
Mol Reprod Dev; 2009 Mar; 76(3):309-17. PubMed ID: 18729084
[TBL] [Abstract][Full Text] [Related]
3. The proximal promoter region of mTert is sufficient to regulate telomerase activity in ES cells and transgenic animals.
Pericuesta E; Ramírez MA; Villa-Diaz A; Relaño-Gines A; Torres JM; Nieto M; Pintado B; Gutiérrez-Adán A
Reprod Biol Endocrinol; 2006 Feb; 4():5. PubMed ID: 16457732
[TBL] [Abstract][Full Text] [Related]
4. Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers.
Gu J; Kagawa S; Takakura M; Kyo S; Inoue M; Roth JA; Fang B
Cancer Res; 2000 Oct; 60(19):5359-64. PubMed ID: 11034071
[TBL] [Abstract][Full Text] [Related]
5. CEBP factors regulate telomerase reverse transcriptase promoter activity in whey acidic protein-T mice during mammary carcinogenesis.
Kumar M; Witt B; Knippschild U; Koch S; Meena JK; Heinlein C; Weise JM; Krepulat F; Kuchenbauer F; Iben S; Rudolph KL; Deppert W; Günes C
Int J Cancer; 2013 May; 132(9):2032-43. PubMed ID: 23023397
[TBL] [Abstract][Full Text] [Related]
6. Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter.
Komata T; Kondo Y; Kanzawa T; Hirohata S; Koga S; Sumiyoshi H; Srinivasula SM; Barna BP; Germano IM; Takakura M; Inoue M; Alnemri ES; Shay JW; Kyo S; Kondo S
Cancer Res; 2001 Aug; 61(15):5796-802. PubMed ID: 11479218
[TBL] [Abstract][Full Text] [Related]
7. The utrophin promoter A drives high expression of the transgenic LacZ gene in liver, testis, colon, submandibular gland, and small intestine.
Takahashi J; Itoh Y; Fujimori K; Imamura M; Wakayama Y; Miyagoe-Suzuki Y; Takeda S
J Gene Med; 2005 Feb; 7(2):237-48. PubMed ID: 15538725
[TBL] [Abstract][Full Text] [Related]
8. Long-range enhancers are required to maintain expression of the autoantigen islet-specific glucose-6-phosphatase catalytic subunit-related protein in adult mouse islets in vivo.
Wang Y; Flemming BP; Martin CC; Allen SR; Walters J; Oeser JK; Hutton JC; O'Brien RM
Diabetes; 2008 Jan; 57(1):133-41. PubMed ID: 17942825
[TBL] [Abstract][Full Text] [Related]
9. TERT over-expression affects the growth of myocardial tissue derived from mouse embryonic stem cells.
Brandt S
Differentiation; 2010 Jan; 79(1):1-8. PubMed ID: 19811869
[TBL] [Abstract][Full Text] [Related]
10. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
Song Y; Shen K; He CX
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
[TBL] [Abstract][Full Text] [Related]
11. The human cGMP-PDE beta-subunit promoter region directs expression of the gene to mouse photoreceptors.
Ogueta SB; Di Polo A; Flannery JG; Yamashita CK; Farber DB
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4059-63. PubMed ID: 11095595
[TBL] [Abstract][Full Text] [Related]
12. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
Song Y; Shen K; Yu JR
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
[TBL] [Abstract][Full Text] [Related]
13. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance.
Alonso MM; Fueyo J; Shay JW; Aldape KD; Jiang H; Lee OH; Johnson DG; Xu J; Kondo Y; Kanzawa T; Kyo S; Bekele BN; Zhou X; Nigro J; McDonald JM; Yung WK; Gomez-Manzano C
J Natl Cancer Inst; 2005 Nov; 97(21):1589-600. PubMed ID: 16264179
[TBL] [Abstract][Full Text] [Related]
14. Characterization of tetracycline-inducible bitransgenic Krt12rtTA/+/tet-O-LacZ mice.
Chikama T; Hayashi Y; Liu CY; Terai N; Terai K; Kao CW; Wang L; Hayashi M; Nishida T; Sanford P; Doestchman T; Kao WW
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):1966-72. PubMed ID: 15914610
[TBL] [Abstract][Full Text] [Related]
15. Cell lines and transgenic mice expressing a matrix metalloproteinase-9 promoter-driven reporter gene: potential for assay of ultraviolet light effects and light-inhibiting compounds.
Bargagna-Mohan P; Mohan R; Russo L; Kochevar IE; Fini ME
Cutan Ocul Toxicol; 2007; 26(4):383-97. PubMed ID: 18058311
[TBL] [Abstract][Full Text] [Related]
16. Astrocyte heterogeneity revealed by expression of a GFAP-LacZ transgene.
Lee Y; Su M; Messing A; Brenner M
Glia; 2006 May; 53(7):677-87. PubMed ID: 16482522
[TBL] [Abstract][Full Text] [Related]
17. Expression of beta-galactosidase under the control of the human c-myc promoter in transgenic mice is inhibited by mithramycin.
Jones DE; Cui DM; Miller DM
Oncogene; 1995 Jun; 10(12):2323-30. PubMed ID: 7784080
[TBL] [Abstract][Full Text] [Related]
18. Cloning of mouse telomerase reverse transcriptase gene promoter and identification of proximal core promoter sequences essential for the expression of transgenes in cancer cells.
Si SY; Song SJ; Zhang JZ; Liu JL; Liang S; Feng K; Zhao G; Tan XQ
Oncol Rep; 2011 Aug; 26(2):377-82. PubMed ID: 21567104
[TBL] [Abstract][Full Text] [Related]
19. The promoter of human telomerase reverse transcriptase is activated during liver regeneration and hepatocyte proliferation.
Sirma H; Kumar M; Meena JK; Witt B; Weise JM; Lechel A; Ande S; Sakk V; Guguen-Guillouzo C; Zender L; Rudolph KL; Günes C
Gastroenterology; 2011 Jul; 141(1):326-37, 337.e1-3. PubMed ID: 21447332
[TBL] [Abstract][Full Text] [Related]
20. [Study on cloning of hTERT promoter and its targeting transcriptional activities in telomerase-positive lung cancer cells].
Wang YP; Tang XJ; Chen XH; Che GW; Zhu DX; Sun ZL; Zhou QH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):497-501. PubMed ID: 16909587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
